Literature DB >> 16054245

Ion transport blockers inhibit human rhinovirus 2 release.

Elena V Gazina1, David N Harrison, Meryem Jefferies, Heneu Tan, David Williams, David A Anderson, Steven Petrou.   

Abstract

Picornavirus replication causes leakage of cytoplasmic K+ and an influx of Na+ and Ca2+. In this study, we have explored the possibility that a blockade of Ca2+ and Na+ influx would reduce rhinovirus production and/or release. The Ca2+-channel blockers, verapamil and diltiazem, as well as the blocker of Na+/H+ exchange and the epithelial Na+ channel, EIPA, inhibited both virus production and release. The effect on virus release was more pronounced than the effect on production, thus raising the possibility that rhinovirus release may serve as a target for antiviral agents. Unexpectedly, our results also showed that the antiviral activity of the Ca2+-channel blockers was not due to the block of Ca2+ influx. Similarly, the antiviral activity of EIPA appeared to be unrelated to the blockade of cellular Na+/H+ exchanger or the epithelial Na+ channel. Potential alternative mechanisms of the antiviral activity of these compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054245     DOI: 10.1016/j.antiviral.2005.05.003

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  11 in total

1.  Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes.

Authors:  Amanda D Stuart; T David K Brown
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Human rhinovirus 14 enters rhabdomyosarcoma cells expressing icam-1 by a clathrin-, caveolin-, and flotillin-independent pathway.

Authors:  Abdul Ghafoor Khan; Angela Pickl-Herk; Leszek Gajdzik; Thomas C Marlovits; Renate Fuchs; Dieter Blaas
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

3.  Coxsackievirus A9 infects cells via nonacidic multivesicular bodies.

Authors:  Moona Huttunen; Matti Waris; Ritva Kajander; Timo Hyypiä; Varpu Marjomäki
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Amiloride derivatives inhibit coxsackievirus B3 RNA replication.

Authors:  David N Harrison; Elena V Gazina; Damian F Purcell; David A Anderson; Steven Petrou
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

5.  The Attenuation Phenotype of a Ribavirin-Resistant Porcine Reproductive and Respiratory Syndrome Virus Is Maintained during Sequential Passages in Pigs.

Authors:  Amina Khatun; Nadeem Shabir; Byoung-Joo Seo; Bum-Seok Kim; Kyoung-Jin Yoon; Won-Il Kim
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds.

Authors:  Laura I Levi; Nina F Gnädig; Stéphanie Beaucourt; Malia J McPherson; Bruno Baron; Jamie J Arnold; Marco Vignuzzi
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

7.  Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.

Authors:  H-Heinrich Hoffmann; Peter Palese; Megan L Shaw
Journal:  Antiviral Res       Date:  2008-06-13       Impact factor: 5.970

8.  Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virus.

Authors:  Amina Khatun; Nadeem Shabir; Kyoung-Jin Yoon; Won-Il Kim
Journal:  BMC Vet Res       Date:  2015-02-07       Impact factor: 2.741

9.  The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.

Authors:  Gerrit Gehring; Katrin Rohrmann; Nkacheh Atenchong; Eva Mittler; Stephan Becker; Franziska Dahlmann; Stefan Pöhlmann; Florian W R Vondran; Sascha David; Michael P Manns; Sandra Ciesek; Thomas von Hahn
Journal:  J Antimicrob Chemother       Date:  2014-04-07       Impact factor: 5.790

10.  Antiviral effect of amiloride on replication of foot and mouth disease virus in cell culture.

Authors:  Mei-Jiao Gong; Yan-Yan Chang; Jun-Jun Shao; Shi-Fang Li; Yong-Guang Zhang; Hui-Yun Chang
Journal:  Microb Pathog       Date:  2019-07-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.